secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zeo ScientifiX, Inc. (ZEOX)
CIK:        0001557376
Form:       8-K
Filed at:   2026-07-08T12:00:28+00:00
Accession:  0001829126-26-007394
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zeo ScientifiX Q1 FY2026 revenue up 124.6% to $2.58M; net loss narrows to ~$1.0M
--------------------------------------------------------------------------------

- Revenue for quarter ended Apr 30, 2026: $2.58M vs $1.15M a year ago, +124.6%.
- Six-month revenue: $4.03M vs $2.24M, +79.9%, driven by allogenic biologic products.
- Gross margins maintained at ~80% for both six-month periods.
- Net loss for six months reduced to ~$1.0M from ~$2.6M in prior-year period.
- CEO cites growing physician adoption and commercial momentum in Florida.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557376/000182912626007394/0001829126-26-007394-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557376/000182912626007394/zeoscientifix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-007394

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer